Liraglutide has been approved for multiple indications since its initial launch in 2010: 2010: Victoza approved for adults with type 2 diabetes 2014: Brand name Saxenda approved for obesity in adults 2017: Victoza approved for reducing the risk of major adverse cardiovascular (CV) events, heart attack, stroke, and CV death in adults with type 2 diabetes and established CV disease 2019: Victoza approved for pediatric patients aged ten and over with type 2 diabetes 2020: Saxenda approved for obesity in adolescents aged 12-17 Population According to the CDC, approximately 38 million adults in the United States have diabetes (90-95% is type 2 diabetes)
Carnitine absorbs better when there's a bit of an insulin spike from carbs
[Encourages Healthy Appetite Signals & Satiety*] Promotes feelings of fullness with microbiome-nourishing ingredients like Akkermansia Muciniphila and Chicory Inulin
People have to think of obesity as a long-term condition.
They are available in a variety of formulations, including capsules, tablets, liquids, and powders, allowing for individualization based on preferences
So a careful, individualized approach is necessary for a smooth and safe transition